When to Call On Us

We Can Help You

If you’re developing a point of care diagnostics instrument and you’re focused on developing a strategy for selling it into physician’s offices and the home, or for making it as attractive as possible for a potential acquirer, we can help you.

If you have a number of biomarkers and you’re trying to understand which one(s) to invest in, we can help

If you’re looking for innovative economic and regulatory strategies to get a high-value diagnostic to market, we can help

If you’re looking to invest in high-value diagnostics for long term growth, with potential to dominate in their markets, we can help you

If you’re looking to buy a diagnostics company because it has innovative premium services as well as content, we can help you buy it and grow it afterwards

If you’re looking for due diligence help to see if your candidate can help you succeed in new markets involving molecular medicine, molecular diagnostics, services, information technology, and point of care, we can help you understand the risks and potential available to you.

When GHS May Not Help
When Not to Call

If you’re developing a high throughput diagnostic instrument which you want to sell to a lab, you probably don’t need our help.

If you have a single early-stage biomarker which may have value eventually, we’re not the organization for you.

If you want standard regulatory help for a new drug candidate, there are many firms which can help you.

If you’re looking to buy a diagnostics company solely for its revenues, we can help you, as can other organizations.

If you’re looking for due diligence help which only extrapolates past revenues, there are many firms which can do this work.